• QIA joins USD 250M funding round for Kardium, backing its push to commercialize innovative atrial fibrillation treatment technology.
• Kardium’s Globe System uses advanced catheter tech to treat AFib with precision, aiming for faster, safer heart procedures.
• New funding supports regulatory approvals, manufacturing expansion, and global launch plans for the Globe Pulsed Field System.

QIA

What happened? Canada’s Kardium Inc raised USD 250 million in a financing round. The round was led by Janus Henderson Investors, MMCAP, Piper Heartland Healthcare Capital, Eventide Asset Management, and Eckuity Capital.  Additionally, the investors include T. Rowe Price Associates, Inc., T. Rowe Price Investment Management, Inc., and Durable Capital Partners LP. Most importantly, from the Middle East, Qatar Investment Authority (QIA), participated in this round. 

What is next? With the newly acquired funding, Kardium aims to pursue regulatory approvals for the Globe System. The Globe System is an innovation with potential to improve the lives of patients with atrial fibrillation.

It also aims to expand its manufacturing facilities and production capacity. Furthermore, it aims to establish a clinical support and commercial team in preparation for the anticipated commercial launch of the Globe System. In addition, it also aims to run  further clinical research for additional applications and expanded indications for the Globe System

“This funding enables us to move ahead with the commercial launch of the Globe System by expanding our manufacturing capabilities and building a strong commercial team,” said Kevin Chaplin, CEO of Kardium.

AFib Treatment

How does it work? The Globe Pulsed Field System consists of a sophisticated catheter with a 122-electrode array and advanced software. This aims to enable rapid pulmonary vein isolation, high-definition mapping, and the ability to ablate anywhere in the atrium. This is all achieved with a single catheter.

Who are they? Founded in 2007, Kardium Inc, is a Canadian-based privately held medical solutions company. It has developed an advanced system for atrial fibrillation (AF) treatment named the Globe System.